Your browser is no longer supported. Please, upgrade your browser.
ILMN Illumina Inc. daily Stock Chart
Illumina Inc.
Index- P/E75.89 EPS (ttm)2.90 Insider Own1.10% Shs Outstand144.10M Perf Week0.49%
Market Cap31.71B Forward P/E53.71 EPS next Y4.10 Insider Trans-31.22% Shs Float142.61M Perf Month5.34%
Income430.00M PEG3.61 EPS next Q0.77 Inst Own95.10% Short Float3.10% Perf Quarter20.25%
Sales1.98B P/S16.02 EPS this Y163.30% Inst Trans0.09% Short Ratio3.46 Perf Half Y19.23%
Book/sh11.29 P/B19.49 EPS next Y19.52% ROA13.10% Target Price231.76 Perf Year21.95%
Cash/sh9.48 P/C23.21 EPS next 5Y21.03% ROE31.60% 52W Range145.12 - 223.38 Perf YTD19.23%
Dividend- P/FCF85.29 EPS past 5Y34.90% ROI15.20% 52W High-1.48% Beta0.94
Dividend %- Quick Ratio2.60 Sales past 5Y22.80% Gross Margin70.50% 52W Low51.65% ATR4.12
Employees3700 Current Ratio2.90 Sales Q/Q28.00% Oper. Margin26.30% RSI (14)65.83 Volatility1.88% 1.90%
OptionableYes Debt/Eq0.80 EPS Q/Q130.00% Profit Margin21.70% Rel Volume0.73 Prev Close220.68
ShortableYes LT Debt/Eq0.61 EarningsJul 22 AMC Payout0.00% Avg Volume1.28M Price220.07
Recom1.90 SMA201.71% SMA507.52% SMA20015.40% Volume933,536 Change-0.28%
May-21-15Upgrade Morgan Stanley Equal-Weight → Overweight $162 → $190
Apr-22-15Reiterated Mizuho Buy $220 → $230
Mar-10-15Initiated UBS Buy $240
Jan-28-15Reiterated Stifel Buy $215 → $235
Jan-28-15Reiterated Maxim Group Buy $236 → $255
Jan-07-15Initiated Barclays Equal Weight $210
Oct-27-14Reiterated Stifel Buy $200 → $215
Oct-21-14Reiterated ISI Group Neutral $175 → $180.50
Aug-12-14Initiated Stifel Buy $200
Aug-01-14Initiated Tigress Financial Buy
Jul-24-14Reiterated Mizuho Buy $200 → $220
Jul-17-14Reiterated Maxim Group Buy $205 → $220
Apr-23-14Upgrade Maxim Group Hold → Buy $205
Apr-23-14Reiterated Mizuho Buy $175 → $200
Apr-23-14Reiterated ISI Group Neutral $152.50 → $162.50
Feb-19-14Reiterated UBS Buy $152 → $202
Jan-29-14Reiterated Mizuho Buy $150 → $175
Jan-29-14Reiterated ISI Group Neutral $134.50 → $147
Jan-17-14Reiterated Mizuho Buy $135 → $150
Jan-14-14Reiterated Mizuho Buy $125 → $135
Jul-02-15 11:16AM  Why Illumina The "Marvel" May See a Stock Rise
Jul-01-15 01:29PM  Robbins Arroyo LLP Is Investigating the Officers and Directors of Illumina, Inc. (ILMN) on Behalf of Shareholders PR Newswire
Jun-27-15 06:02PM  Biotech Short-Sellers Prefer Amgen To Gilead Sciences
Jun-26-15 01:30PM  BioMed Realty Signs Build-To-Suit Deal With Illumina in UK - Analyst Blog
Jun-25-15 05:29PM  Illumina, A Gene Research Leader, In Buy Range at Investor's Business Daily
09:31AM  ILLUMINA INC Files SEC form 8-K, Entry into a Material Definitive Agreement
09:17AM  BioMed Realty And Illumina Announce New Build-To-Suit Laboratory Building In Cambridge's Growing Life Science Cluster PR Newswire
Jun-23-15 03:40PM  IBD 50 Stocks Illumina, Avago Tech In Buy Range
02:32PM  Illumina Leads In Medicine's Next Frontier: Genetics at Investor's Business Daily
Jun-22-15 06:35PM  Top Stock INC Up 6 Weeks In Row, Just Out Of Buy Zone at Investor's Business Daily
Jun-17-15 06:52PM  Why Agilent Technologies is a "Hold"
Jun-16-15 03:30PM  San Diego-Based Illumina Inc's Stock Is Overvalued
Jun-15-15 01:47PM  Should Active Managers Blame the Benchmark? at
Jun-12-15 01:27PM  The Intro Guide to Illumina (ILMN): Inside the DNA Sequencing Leader - Stocks in the News
Jun-11-15 06:26AM  Edited Transcript of ILMN presentation 10-Jun-15 5:00pm GMT
Jun-10-15 03:00AM  Annoroad and Illumina to Co-Develop NGS Diagnostic System for Reproductive Health Business Wire
Jun-09-15 07:00PM  IBD Market Wrap - 06/09/15
05:38PM  Illumina Breaks Out To New High On Solid Volume at Investor's Business Daily
12:27PM  4 Stock Picks: Firms That Dominate Their Industries at
Jun-08-15 02:52PM  Stocks Down In Late Trade; CyberArk Gives Up Buy Point at Investor's Business Daily
01:40PM  Bio-Techne to Buy Cliniqa, Boost Clinical Controls Portfolio - Analyst Blog
12:31PM  Illumina Falls On HiSeq Rival; Bio-Reference Up on Q2 at Investor's Business Daily
09:46AM  MannKind (MNKD) Worth a Look: Stock Adds 5.7% in Session - Tale of the Tape
07:00AM  Illumina, Merck KGaA, Darmstadt, Germany, and Genea Form the Global Fertility Alliance for Excellence in Assisted Reproductive Treatment Business Wire
Jun-05-15 01:32PM  Amazon, Google race to get your DNA into the cloud
Jun-01-15 07:00PM  Big Cap Stocks Set Up: Illumina, O'Reilly, Nike at Investor's Business Daily
06:09PM  Earnings Growth Matters A Lot, But Look For Big Estimates Too
09:24AM  Company Aims To Democratize Genetic Tests At $475 A Pop at Forbes
May-29-15 06:31PM  Top Biotech Stock Illumina Hunts For Breakout Gene at Investor's Business Daily
08:56AM  ILLUMINA INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-28-15 02:33PM  The boat indicator
08:46AM  Why the Earnings Streak Will Continue for Illumina (ILMN) - Tale of the Tape
May-27-15 08:00AM  Dozens of Genes in Breast Cancer Tests Have Tenuous Link to Risk at Bloomberg
May-21-15 10:09AM  Illumina upgraded by Morgan Stanley
08:53AM  Weakness Seen in Achillion Pharmaceuticals (ACHN): Stock Tumbles 15.3% - Tale of the Tape
06:30AM  Illumina to Webcast Live Presentation at Upcoming Investment Conferences in June Business Wire
May-20-15 09:50AM  Actavis Plc (ACT), Illumina Inc (LMN) and Cheniere Energy Inc (LNG) Among Billionaire Halvorsens Top Stock picks at Insider Monkey
May-19-15 09:39AM  Billionaire Stanley Druckenmillers Top Value Picks Include Illumina, Inc. (ILMN), Biogen Inc (BIIB), LyondellBasell Industries NV (LYB) at Insider Monkey
08:35AM  Oncothyreon (ONTY) Looks Good: Stock Up 6.6% in Session - Tale of the Tape
May-18-15 06:15PM  Large-Cap Growth Stocks: New Safe Haven For Investors? at Investor's Business Daily
04:05PM  Illumina Files New Patent Infringement Suit Against Ariosa Diagnostics, Inc. and Roche Molecular Systems, Inc. Business Wire
May-15-15 03:35PM  Agenus (AGEN) Provides Update on its Brain Cancer Vaccine - Analyst Blog
11:26AM  Prestige Brands Holdings Beats on Q4 Earnings, Revenues - Analyst Blog
May-13-15 09:40AM  3 Biotech Stocks See Growing Short Interest
May-12-15 04:26PM  BioDelivery (BDSI) Q1 Loss Narrower-Than-Expected - Analyst Blog
09:30AM  Illumina, US Silica Holdings, Shake Shack, Red Robin Gourmet Burgers and Chuy's Holdings highlighted as Zacks Bull and Bear of the Day - Press Releases
08:11AM  Bull of the Day: Illumina (ILMN) - Bull of the Day
May-04-15 12:40PM  Integra LifeSciences Tops Q1 Earnings, Revenues; View Up - Analyst Blog
08:50AM  Can Illumina (ILMN) Stock Continue to Grow Earnings? - Tale of the Tape
May-03-15 08:13PM  10-Q for Illumina, Inc. at Company Spotlight
May-01-15 06:00PM  Cramer's move next week
05:24PM  ILLUMINA INC Files SEC form 10-Q, Quarterly Report
11:55AM  Is it a Miss for TrovaGene (TROV) This Earnings Season? - Analyst Blog
Apr-29-15 07:00AM  DNA Sequencing Market Will Exceed $20 Billion, Says Illumina CEO Jay Flatley at Forbes
06:51AM  Illumina to Webcast Live Presentation at the Bank of America Merrill Lynch Health Care Conference at noodls
06:30AM  Illumina to Webcast Live Presentation at the Bank of America Merrill Lynch Health Care Conference Business Wire
Apr-23-15 10:30AM  3 Top Stocks to Buy That Delivered Great Earnings at 24/7 Wall St.
06:00AM  Intel-Edico partnership aims to break a medical logjam at Fortune
Apr-22-15 06:39PM  Cloud Health Launches Full Service Capacity of the Illumina HiSeq X Ten Sequencing System at noodls
01:35PM  Stocks Higher After Soft Start; Facebook Up Pre-Earnings at Investor's Business Daily
11:53AM  Stocks Mildly Higher; China Nods To Visa, MasterCard at Investor's Business Daily
10:38AM  Stocks Take A Quiet Step Back; McDonald's, Visa, Tesla Climb at Investor's Business Daily
10:15AM  Illumina (ILMN) Tops Q1 Earnings, Revenues; EPS View Up - Analyst Blog
07:58AM  Illumina (ILMN) Earnings Report: Q1 2015 Conference Call Transcript at TheStreet
Apr-21-15 06:44PM  Yum! Brands, Chipotle, United Rentals Lead Tuesday's After-Hours Movers
06:00PM  Amgen, Illumina Earnings Hot, Intuitive Surgical Not at Investor's Business Daily
05:00PM  Illumina Inc Earnings Call scheduled for 5:00 pm ET today
04:27PM  Illumina beats Street 1Q forecasts
04:19PM  Illumina Reports Strong Start to Fiscal Year 2015 at noodls
04:08PM  ILLUMINA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  Illumina Reports Strong Start to Fiscal Year 2015 Business Wire
02:40PM  Will Thermo Fisher's (TMO) Q1 Earnings Surprise Investors? - Analyst Blog
09:56AM  Stocks narrowly mixed amid earnings; Nasdaq leads gains at CNBC
08:08AM  Wall Street optimistic on bumper earnings day at CNBC
07:28AM  Startup Pledges To Cut Cost Of Breast Cancer Genetic Testing From $4000 To $249 at Forbes
07:07AM  Q1 2015 Illumina Inc Earnings Release - After Market Close
Apr-20-15 03:15PM  Billionaire Andreas Halvorsens New Healthcare Pick at Insider Monkey
09:01AM  Immune System Drugs Melt Tumors In New Study, Leading A Cancer Revolution at Forbes
Apr-17-15 01:40PM  Can Illumina (ILMN) Keep the Earnings Streak Alive in Q1? - Analyst Blog
Apr-15-15 08:54AM  Why Illumina (ILMN) Might Surprise This Earnings Season - Tale of the Tape
Apr-14-15 05:30PM  Douglas C. Lane's Top Three Stocks for Q1 2015: Delta, United Continental and Illumina
Apr-08-15 12:02PM  It Takes Two To Tango: Combine Diagnostics And Drugs For Precision Medicine at Forbes
Apr-07-15 06:32AM  Illumina to Announce First Quarter 2015 Financial Results on Tuesday, April 21, 2015 at noodls
06:30AM  Illumina to Announce First Quarter 2015 Financial Results on Tuesday, April 21, 2015 Business Wire
Apr-01-15 08:14PM  Fetal DNA tests prove highly accurate but experts warn of exceptions Reuters
Mar-31-15 09:24AM  Berry Genomics NextSeq CN500 Instrument and Non-Invasive Prenatal Testing Reagent Kit Receives Chinese FDA Premarket Clearance at noodls
09:19AM  Berry Genomics NextSeq CN500 Instrument and Non-Invasive Prenatal Testing Reagent Kit Receives Chinese FDA Premarket Clearance Business Wire
Mar-27-15 09:30AM  The Zacks Analyst Blog Highlights: Methode Electronics, Newmont Mining, Valero Energy and Quest Diagnostics - Press Releases
09:30AM  The Zacks Analyst Blog Highlights: Horizon Pharma, NewLink Genetic and llumina - Press Releases
Mar-26-15 03:35PM  3 Biotech Stocks Bucking Short Interest Trends
02:55PM  The March Madness 'Sweet 16' of Stocks - Analyst Blog
02:12PM  Biotech Battering Renews Bubble Debate Over Sector's Pricey Stocks at Forbes
10:21AM  Biotech Crash -- How Long Will It Last? at Forbes
Mar-25-15 07:22PM  3 Excellent Biotech Stocks to Buy on the Dip - Stocks in the News
Mar-23-15 05:45PM  Health Care REIT Stocks Find Investors' Favor at Investor's Business Daily
10:03AM  Illumina Launches the NeoPrep Library Prep System at noodls
09:35AM  Illumina Names Albiogen as Eastern Europe Distributor at noodls
09:35AM  Illumina Launches TruSight HLA Solution at noodls
09:35AM  Illumina Files Patent Infringement Suit in the United Kingdom Against Premaitha Health plc for Infringement of NIPT Patents at noodls
09:35AM  Illumina Announces Strategic Collaboration with Merck Serono to Expand Companion Diagnostics for Oncology at noodls
Illumina, Inc. provides sequencing and array-based solutions for genetic analysis in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa. The company's products include sequencing platforms that are based on its SBS technology, which provides researchers with various ranges of applications and the ability to sequence mammalian genomes; and array platforms consist of HiScan and iScan systems, as well as NextSeq 550 system that are array scanners for DNA and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis. It also offers various library preparation and sequencing kits to simplify workflows and accelerate analysis. In addition, the company provides genotyping, noninvasive prenatal test, and whole-genome sequencing services. It serves genomic research centers, academic institutions, government laboratories, hospitals, and reference laboratories, as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic, and consumer genomics companies. The company sells its products directly, as well as through distributors. It has a collaboration agreement with Merck Serono to develop a sequencing-based oncology diagnostic. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WALT DAVID RDirectorJun 30Sale217.6410,0002,176,449704,337Jun 30 05:56 PM
Dadswell CharlesSr VP & General CounselJun 29Sale215.6316034,50142,662Jun 29 06:30 PM
FLATLEY JAY TChief Executive OfficerJun 25Option Exercise32.6325,000815,750449,996Jun 26 04:28 PM
FLATLEY JAY TChief Executive OfficerJun 25Sale220.3425,0005,508,403424,996Jun 26 04:28 PM
BRADBURY DANIELDirectorJun 24Option Exercise75.661,700128,62216,076Jun 24 06:28 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficJun 24Sale221.075,0841,123,90926,722Jun 24 05:25 PM
BRADBURY DANIELDirectorJun 24Sale221.231,700376,09814,376Jun 24 06:28 PM
WALT DAVID RDirectorJun 23Sale220.0910,0002,200,942714,337Jun 24 05:01 PM
WALT DAVID RDirectorJun 23Sale220.172,000440,33152,960Jun 24 05:01 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficJun 17Sale215.713,751809,11231,806Jun 18 11:38 AM
WALT DAVID RDirectorJun 16Sale215.1410,0002,151,374724,337Jun 18 11:34 AM
Naclerio NicholasSr VP, Corporate DevelopmentJun 15Sale214.336,5901,412,45528,277Jun 15 07:49 PM
Bianchi Paul LSr. VP, Human ResourcesJun 15Sale215.833,408735,54961,123Jun 15 07:53 PM
Stapley MarcSr VP & CFOJun 12Option Exercise36.302,40087,12020,898Jun 15 07:38 PM
Bouchard MichelChief Accounting OfficerJun 12Sale216.111,400302,55415,008Jun 15 07:05 PM
Stapley MarcSr VP & CFOJun 12Sale214.903,000644,70117,898Jun 15 07:38 PM
FLATLEY JAY TChief Executive OfficerJun 11Option Exercise33.8025,000844,875449,996Jun 12 09:49 PM
FLATLEY JAY TChief Executive OfficerJun 11Sale216.4125,0005,410,350424,996Jun 12 09:49 PM
EPSTEIN ROBERT SDirectorJun 10Option Exercise51.172,000102,34011,460Jun 11 05:12 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficJun 10Option Exercise69.3410,000693,40045,557Jun 11 06:28 PM
EPSTEIN ROBERT SDirectorJun 10Sale214.242,000428,4809,460Jun 11 05:12 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficJun 10Sale214.9410,0002,149,41435,557Jun 11 06:28 PM
WALT DAVID RDirectorJun 09Sale213.4810,0002,134,778734,337Jun 11 09:15 PM
WALT DAVID RDirectorJun 09Sale213.642,000427,28554,960Jun 11 09:15 PM
WHITFIELD ROY ADirectorJun 05Option Exercise39.144,500176,13018,148Jun 08 02:41 PM
WHITFIELD ROY ADirectorJun 05Sale207.494,500933,70513,648Jun 08 02:41 PM
OSTADAN OMEADSr VP Product Dev & OperationsJun 04Sale206.25874180,26346,783Jun 05 08:06 PM
WALT DAVID RDirectorJun 02Sale204.4210,0002,044,150744,337Jun 04 07:18 PM
EASTHAM KARINDirectorJun 01Option Exercise39.145,000195,70015,419Jun 03 07:47 PM
EASTHAM KARINDirectorJun 01Sale205.245,0001,026,21611Jun 03 07:47 PM
BRADBURY DANIELDirectorMay 29Option Exercise75.661,700128,62216,076Jun 01 07:24 PM
BRADBURY DANIELDirectorMay 29Sale206.621,700351,25414,376Jun 01 07:24 PM
FLATLEY JAY TChief Executive OfficerMay 28Option Exercise33.8025,000844,875449,996May 29 07:05 PM
FLATLEY JAY TChief Executive OfficerMay 28Sale208.7825,0005,219,502424,996May 29 07:05 PM
Dadswell CharlesSr VP & General CounselMay 27Sale206.6217035,12541,652May 28 08:04 PM
WALT DAVID RDirectorMay 26Sale204.7410,0002,047,382752,427May 28 07:26 PM
WALT DAVID RDirectorMay 26Sale204.792,000409,58356,960May 28 07:26 PM
BOWMAN A BLAINEDirectorMay 22Option Exercise39.143,000117,42015,722May 26 08:25 PM
BOWMAN A BLAINEDirectorMay 22Sale204.583,000613,74812,722May 26 08:25 PM
WALT DAVID RDirectorMay 19Sale202.0010,0002,020,042762,427May 19 06:07 PM
Naclerio NicholasSr VP, Corporate DevelopmentMay 15Sale199.166,5901,312,48734,867May 19 05:31 PM
FLATLEY JAY TChief Executive OfficerMay 14Option Exercise33.8025,000844,875449,996May 15 09:06 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficMay 14Sale198.523,751744,64035,557May 15 08:55 PM
FLATLEY JAY TChief Executive OfficerMay 14Sale197.7625,0004,944,122424,996May 15 09:06 PM
Bianchi Paul LSr. VP, Human ResourcesMay 13Sale197.143,356661,60264,531May 14 07:14 PM
Stapley MarcSr VP & CFOMay 12Option Exercise36.302,40087,12021,498May 14 08:10 PM
WALT DAVID RDirectorMay 12Sale196.205,000981,020772,427May 14 07:07 PM
WALT DAVID RDirectorMay 12Sale196.292,000392,58058,960May 14 07:07 PM
Bouchard MichelChief Accounting OfficerMay 12Sale195.721,400274,00819,208May 14 07:28 PM
Stapley MarcSr VP & CFOMay 12Sale196.163,000588,46618,498May 14 08:10 PM
EPSTEIN ROBERT SDirectorMay 11Option Exercise51.172,000102,3409,042May 12 09:28 PM
EPSTEIN ROBERT SDirectorMay 11Sale196.492,000392,9807,042May 12 09:28 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficMay 05Option Exercise69.3411,500797,41050,808May 07 06:29 PM
WHITFIELD ROY ADirectorMay 05Option Exercise39.144,500176,13016,238May 07 06:58 PM
WALT DAVID RDirectorMay 05Sale186.275,000931,344777,427May 07 06:14 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficMay 05Sale186.6011,5002,145,91439,308May 07 06:29 PM
WHITFIELD ROY ADirectorMay 05Sale188.424,500847,89011,738May 07 06:58 PM
Dadswell CharlesSr VP & General CounselApr 30Sale185.8812923,97941,822May 01 07:57 PM
WALT DAVID RDirectorApr 28Sale183.865,000919,294782,427Apr 30 07:00 PM
WALT DAVID RDirectorApr 28Sale183.922,000367,83460,960Apr 30 07:00 PM
Dadswell CharlesSr VP & General CounselApr 27Sale190.04346,46141,951Apr 28 07:25 PM
BOWMAN A BLAINEDirectorApr 24Option Exercise39.143,000117,42015,722Apr 28 07:14 PM
BOWMAN A BLAINEDirectorApr 24Sale190.733,000572,19912,722Apr 28 07:14 PM
FLATLEY JAY TChief Executive OfficerApr 23Option Exercise33.8025,000844,875449,996Apr 27 05:54 PM
FLATLEY JAY TChief Executive OfficerApr 23Sale189.5725,0004,739,274424,996Apr 27 05:54 PM
WALT DAVID RDirectorApr 21Sale197.9510,0001,979,515787,427Apr 23 07:21 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficApr 15Sale189.023,751709,02139,308Apr 16 06:38 PM
Naclerio NicholasSr VP, Corporate DevelopmentApr 15Sale189.056,5901,245,81041,457Apr 16 06:33 PM
WALT DAVID RDirectorApr 14Sale188.255,000941,247797,427Apr 15 06:59 PM
WALT DAVID RDirectorApr 14Sale188.172,000376,33662,960Apr 15 06:59 PM
Stapley MarcSr VP & CFOApr 13Option Exercise36.302,40087,12022,098Apr 15 06:26 PM
Bianchi Paul LSr. VP, Human ResourcesApr 13Sale187.223,390634,67667,887Apr 15 06:00 PM
Stapley MarcSr VP & CFOApr 13Sale190.123,000570,37319,098Apr 15 06:26 PM
Bouchard MichelChief Accounting OfficerApr 13Sale188.611,400264,05420,608Apr 15 07:11 PM
FLATLEY JAY TChief Executive OfficerApr 09Option Exercise33.8025,000844,875449,996Apr 13 07:02 PM
FLATLEY JAY TChief Executive OfficerApr 09Sale184.5525,0004,613,815424,996Apr 13 07:02 PM
BRADBURY DANIELDirectorApr 08Option Exercise75.661,700128,62214,166Apr 10 06:55 PM
BRADBURY DANIELDirectorApr 08Sale185.321,700315,04212,466Apr 10 06:55 PM
WALT DAVID RDirectorApr 07Sale184.285,000921,404802,427Apr 08 09:16 PM
WHITFIELD ROY ADirectorApr 06Option Exercise19.614,60090,20616,338Apr 08 07:40 PM
WHITFIELD ROY ADirectorApr 06Sale181.324,600834,07211,738Apr 08 07:40 PM
WALT DAVID RDirectorMar 31Sale186.005,000930,001807,427Apr 02 07:15 PM
WALT DAVID RDirectorMar 31Sale185.982,000371,95264,960Apr 02 07:15 PM
Dadswell CharlesSr VP & General CounselMar 27Sale184.629918,27742,690Mar 31 05:51 PM
FLATLEY JAY TChief Executive OfficerMar 26Option Exercise33.8025,000844,875449,996Mar 30 08:23 PM
FLATLEY JAY TChief Executive OfficerMar 26Sale181.3425,0004,533,467424,996Mar 30 08:23 PM
WALT DAVID RDirectorMar 24Sale192.165,000960,791812,427Mar 26 08:19 PM
BOWMAN A BLAINEDirectorMar 17Option Exercise39.143,000117,42015,722Mar 19 08:58 PM
BOWMAN A BLAINEDirectorMar 17Sale192.303,000576,90812,722Mar 19 08:58 PM
WALT DAVID RDirectorMar 17Sale192.575,000962,836817,427Mar 19 07:52 PM
WALT DAVID RDirectorMar 17Sale192.602,000385,19666,960Mar 19 07:52 PM
MOELLER GERALDDirectorMar 16Option Exercise75.662,700204,28220,244Mar 18 08:46 PM
BRADBURY DANIELDirectorMar 16Option Exercise75.661,700128,62214,166Mar 18 08:47 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficMar 16Sale191.595,001958,16243,059Mar 18 08:47 PM
MOELLER GERALDDirectorMar 16Sale193.362,700522,07317,544Mar 18 08:46 PM
Naclerio NicholasSr VP, Corporate DevelopmentMar 16Sale193.946,5901,278,05748,047Mar 18 08:46 PM
BRADBURY DANIELDirectorMar 16Sale194.111,700329,99412,466Mar 18 08:47 PM
Bianchi Paul LSr. VP, Human ResourcesMar 13Sale186.673,390632,81171,277Mar 16 06:21 PM
Stapley MarcSr VP & CFOMar 12Option Exercise36.302,40087,12023,012Mar 13 07:36 PM
FLATLEY JAY TChief Executive OfficerMar 12Option Exercise33.8025,000844,875452,850Mar 16 06:46 PM